Exploring the antigenic diversity of maxadilan, a sand fly salivary protein, and its implications for controlling American visceral leishmaniasis.
Discover how cathepsin B inhibitors reprogram CD4+ T cell differentiation from Th2 to Th1 in leishmaniasis, offering new therapeutic approaches for parasitic infections.